Episode Details
Back to Episodes
Episode 25: A genome-editing first, Trump on Wall Street, and biotech red flags
Published 8 years, 1 month ago
Description
Can genome-editing work in actual people? Are CEOs oversharing? And how do you sniff out a bad bet before it happens?